IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 221 filers reported holding IVERIC BIO INC in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,489,975 | +130.0% | 139,552 | +42.3% | 2.51% | +29.2% |
| Q1 2023 | $2,386,627 | +13.6% | 98,094 | 0.0% | 1.94% | +55.9% |
| Q4 2022 | $2,100,193 | +243.7% | 98,094 | +188.0% | 1.25% | +257.3% |
| Q3 2022 | $611,000 | +9.7% | 34,060 | -41.2% | 0.35% | +3.9% |
| Q2 2022 | $557,000 | -38.2% | 57,919 | +8.1% | 0.34% | -41.4% |
| Q1 2022 | $902,000 | -46.7% | 53,583 | -47.0% | 0.57% | -57.4% |
| Q4 2021 | $1,691,000 | +65.0% | 101,144 | +60.3% | 1.35% | +98.5% |
| Q3 2021 | $1,025,000 | +36.5% | 63,107 | -47.0% | 0.68% | +27.2% |
| Q2 2021 | $751,000 | -13.9% | 118,965 | -15.7% | 0.53% | -17.7% |
| Q1 2021 | $872,000 | +7.8% | 141,055 | +20.5% | 0.65% | +25.3% |
| Q4 2020 | $809,000 | +49.5% | 117,060 | +22.0% | 0.52% | +31.2% |
| Q3 2020 | $541,000 | – | 95,975 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 2,914,250 | $28,035,000 | 11.91% |
| Ally Bridge Group (NY) LLC | 650,000 | $6,253,000 | 5.70% |
| Vivo Capital, LLC | 5,238,634 | $50,396,000 | 5.06% |
| COMMODORE CAPITAL LP | 2,409,961 | $23,184,000 | 4.90% |
| Finepoint Capital LP | 987,600 | $9,501,000 | 3.28% |
| ACUTA CAPITAL PARTNERS, LLC | 563,607 | $5,422,000 | 3.02% |
| Deep Track Capital, LP | 4,500,000 | $43,290,000 | 2.85% |
| Yiheng Capital Management, L.P. | 5,058,585 | $48,664,000 | 2.78% |
| Samsara BioCapital, LLC | 1,010,051 | $9,717,000 | 2.59% |
| Ghost Tree Capital, LLC | 500,000 | $4,810,000 | 2.50% |